Cladribine

Description

Cladribine is a prescription injectable medication used as a chemotherapy drug to treat certain blood cancers, such as hairy cell leukemia. It works as a purine antimetabolite to interfere with cancer cell growth. Manufactured by Fresenius Kabi USA, LLC, it's administered intravenously at a strength of 1 mg/mL in single-dose vials. Approved under ANDA076571 since 2004. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Cladribine — ANDA 218425 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218425

Tags

  • fda
  • public-health
  • drug
  • pharmaceuticals
  • medications

Topics

Categories